Director, Oncology Imaging

At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you.

Eisai is looking for a scientifically driven imaging expert with deep knowledge of Oncology clinical trials to shape the future of imaging science across its development portfolio. This role offers the opportunity to lead high-impact imaging strategies—from trial design and execution to data interpretation—while driving scientific innovation and operational excellence. The successful candidate will spearhead the development of imaging acquisition strategies, biomarkers, and advanced analytics to support translational and clinical goals. At the same time, they will ensure data quality, harmonization across teams, and continuous process improvement, making a measurable difference in how Oncology trials are executed and interpreted.

Essential Functions

• Collaboratively set and lead the strategic direction for Oncology Imaging, guiding protocol design—including modality selection, timing, and anatomical coverage—to ensure alignment with study endpoints and biomarker objectives across Eisai’s clinical pipeline.
• Provide expert guidance on conventional (CT, MRI and FDG PET) and advanced imaging techniques (e.g., diffusion-weighted MRI, dynamic contrast-enhanced imaging, PET tracers beyond FDG, and radiomics) to ensure imaging strategies are optimized for clinical trial design and aligned with scientific objectives.
• Design and execute exploratory imaging analyses using computational tools (e.g., Python, MATLAB, R) to enhance mechanistic understanding and support integrated biomarker strategies—such as extracting quantitative features to correlate with clinical outcomes or analyzing relationships between imaging-derived metrics and fluid biomarkers.
• Lead imaging-related scientific publications and conference presentations to disseminate findings and elevate Eisai’s visibility in Oncology Imaging.
• Serve as imaging science lead in translational collaborations with academic institutions, consortia, and technology partners.
• Provide oversight of imaging core laboratory activities, including the review and approval of key study documents—such as image review charters, site imaging manuals, and transmittal forms—and contribute to the development and approval of clinical data transfer specifications, including CRF data supporting core lab reads and imaging data exports to Eisai.
• Ensure the receipt of clean, accurate, and protocol-compliant independent tumor assessment data, while contributing to the imaging and tumor assessment components of key study documents—including the PCS, protocol, ICF, CRFs, SAP, TLGs, and CSR.
• Provide oversight of scan reconciliation and issue resolution in collaboration with imaging core labs, clinical operations, and data management, and contribute to tumor assessment data cleaning for both investigator and independent reviews.
• Support reporting of imaging activities and progress to study teams and leadership, ensuring visibility into key milestones and initiatives.
• Assist global clinical operations during health authority inspections related to tumor assessments and procedures.

Requirements

• PhD required in related scientific discipline.
• Minimum ten (10) years of experience working on clinical trials with imaging aspects required, from protocol development to final analysis and clinical study reporting.
• Familiarity with oncology image-based tumor response criteria such as RECIST 1.1.
• Experience in oversight and management of imaging CROs.

Eisai Salary Transparency Language:

The base salary range for the Director, Oncology Imaging is from :217,000-284,800

Under current guidelines, this position is eligible to participate in : Eisai Inc. Annual Incentive Plan & Eisai Inc. Long Term Incentive Plan.

Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills.

Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit https://us.eisai.com/careers-at-eisai/benefits.

Certain other benefits may be available for this position, please discuss any questions with your recruiter.

Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.

Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information:

Right To Work

E-Verify Participation